# To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel

> **NCT03094403** · PHASE1 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 1000 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** Azelaic Acid 15% topical gel
- **DRUG:** Finacea® (azelaic acid) Gel, 15%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03094403
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-01
- **Primary completion:** 2017-03-31
- **Final completion:** 2017-04-01
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2024-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03094403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03094403, "To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03094403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*